Skip to main content
Atrás
Watch Compare

Ping An Biomedical Co., Ltd.

Calidad de datos: 100%
PASW
Nasdaq Manufacturing Apparel
$0.15
▲ $0.00 (0.80%)
Cap. Mercado: 18.00 M
Precio
$0.15
Cap. Mercado
18.00 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Negative free cash flow of -902,902.0

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-28.36%
Above sector avg (-53.41%)
ROIC-20.99%
Net Margin-37.57%
Op. Margin-43.05%

Seguridad

Debt / Equity
N/A
Current Ratio0.77
Interest Coverage-47.88

Valoración

PE (TTM)
-9.99
Below sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -10.0 -1.5
P/B — 1.6
ROE % -28.4 -53.4
Net Margin % -37.6 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4.80 M Net Income (TTM) -1.80 M
ROE -28.36% ROA -18.75%
Gross Margin 2.78% Operating Margin -43.05%
Net Margin -37.57% Free Cash Flow (TTM) -902,902.0
ROIC -20.99% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.77
Interest Coverage -47.88 Asset Turnover 0.50
Working Capital -1.93 M Tangible Book Value -1.62 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -9.99 Forward P/E N/A
P/B Ratio N/A P/S Ratio 3.75
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -5.02%
Market Cap 18.00 M Enterprise Value 19.36 M
Per Share
EPS (Diluted TTM) -0.10 Revenue / Share 0.04
FCF / Share -0.01 OCF / Share -0.01
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 50.10%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025
Revenue 4.80 M
Net Income -1.80 M
EPS (Diluted) -0.10
Gross Profit 133,376.0
Operating Income -2.07 M
EBITDA —
R&D Expenses —
SG&A Expenses —
D&A —
Interest Expense 43,132.0
Income Tax 260,653.0

Balance Sheet

Annual, most recent first
Metric FY2025
Total Assets 9.61 M
Total Liabilities 3.26 M
Shareholders' Equity 6.36 M
Total Debt 1.40 M
Cash & Equivalents 164,697.0
Current Assets 8.95 M
Current Liabilities 3.24 M